Clinical Trials Browser

INDUSTRY × Glioblastoma × Hydroxyurea × Clear all

NCT00290771 2011-05-16

Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Terminated

231 enrolled 12 charts

Glioblastoma, Glioma

NCT00154375 2011-04-26

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Phase 3 Completed

240 enrolled 8 charts

Adenocarcinoma, Astrocytoma, Brain Neoplasms, Glioblastoma